US Patent 7037707 Method for generating influenza viruses and vaccines
Patent 7037707 was granted and assigned to St. Jude Children's Research Hospital on May, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Nov, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+574 characters)
Article
Patent abstract
The present invention is based on the discovery that a high titer reassortant influenza virus is produced in mammalian cell culture by replacing the NS gene of the A/PuertoRico/3/24 master strain with the NS gene of the A/England/1/53 strain. The invention provides influenza viruses and vaccines generated in mammalian cells as well as methods for producing such. The invention further provides an influenza virus master strain and kits for generating reassortant influenza viruses in mammalian cell culture and methods of making and using the master strain.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Hiroichi Ozaki0
Richard John Webby0
Robert Gordon Webster0
Date of Patent
May 2, 2006
0Patent Application Number
106547370
Date Filed
September 4, 2003
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7037707 Method for generating influenza viruses and vaccines
Find more entities like US Patent 7037707 Method for generating influenza viruses and vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.